Skip to main content
. 2021 Oct 9;57(10):1079. doi: 10.3390/medicina57101079

Table 3.

Circulating metabolites and tissue markers.

Parameter BASAL PB
(n = 15)
BASAL VD
(n = 15)
PB
(n = 15)
VD
(n = 15)
Total proteins (g/dL) 7.1 ± 0.1 7.2 ± 0.1 7.2 ± 0.1 7.2 ± 0.1
Uric acid (mg/dL) 4.8 ± 0.4 4.9 ± 0.5 4.9 ± 0.3 5.3 ± 0.4
Creatinine (mg/dL) 1.3 ± 0.1 1.4 ± 0.2 1.2 ± 0.0 1.3 ± 0.1
AST (U/L) 34.3 ± 3.4 30.9 ± 2.2 31.3 ± 2.2 33.1 ± 2.5
ALT (U/L) 24.8 ± 1.6 24.8 ± 3.1 24.6 ± 1.3 25.6 ± 2.0
GGT (U/L) 18.9 ± 1.7 19.6 ± 1.4 18.6 ± 1.7 19.0 ± 2.5
CK (U/L) 145.9 ± 99.5 139.1 ± 93.2 158.6 ± 88.0 127.2 ± 85.1 *
LDH (U/L) 381.5 ± 18.7 379.7 ± 20.0 373.1 ± 20.5 386.2 ± 17.7
ALD (U/L) 7.0 ± 0.5 7.3 ± 0.4 7.1 ± 0.5 7.2 ± 0.7
CRP (mg/L) 2.3 ± 2.0 2.3 ± 2.4 3.1 ± 2.2 2.5 ± 1.9
Cortisol (µg/dL) 18.7 ± 1.2 18.8 ± 1.8 17.2 ± 1.3 19.8 ± 1.3

* Indicates significant differences comparing the intervention group VD with respect to the corresponding basal value (Wilcoxon’s paired test). Abbreviations used: ALD, aldolase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CK, creatine kinase; CRP, C-reactive protein; GGT, gamma-glutamyl transferase; LDH, lactate dehydrogenase; PB, placebo group; VD, vitamin D-supplemented group.